Bromazepam is not approved for marketing in the United States by the U.S. Food and Drug Administration but is available in other countries. The death of a newborn infant breastfed by a mother who was apparently using bromazepam has been reported. If a mother of an older infant requires bromazepam, it is not a reason to discontinue breastfeeding; however, an alternate drug is preferred, especially while nursing a newborn, preterm or sick infant.
溴西泮未被美国食品药品监督管理局批准在美国上市，但在其他国家有售。曾有报道称，一名明显正在服用溴西泮的母亲所哺乳的新生儿死亡。如果大龄婴儿的母亲需要服用溴西泮，这并非停止母乳喂养的理由；然而，首选替代药物，尤其是在哺育新生儿、早产或患病婴儿期间。
